Not applicableLooking for participantsNCT07168993
What this trial is testing
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
Who this might be right for
Lung Cancer (Diagnosis)
bioAffinity Technologies Inc. 2,063